Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
2000 2
2001 2
2002 1
2003 1
2006 1
2007 4
2008 3
2009 5
2010 8
2011 10
2012 4
2013 6
2014 7
2015 11
2016 17
2017 8
2018 8
2019 6
2020 17
2021 15
2022 22
2023 15
2024 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

174 results

Results by year

Filters applied: . Clear all
Page 1
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.
Grebely J, Dalgard O, Conway B, Cunningham EB, Bruggmann P, Hajarizadeh B, Amin J, Bruneau J, Hellard M, Litwin AH, Marks P, Quiene S, Siriragavan S, Applegate TL, Swan T, Byrne J, Lacalamita M, Dunlop A, Matthews GV, Powis J, Shaw D, Thurnheer MC, Weltman M, Kronborg I, Cooper C, Feld JJ, Fraser C, Dillon JF, Read P, Gane E, Dore GJ; SIMPLIFY Study Group. Grebely J, et al. Among authors: matthews gv. Lancet Gastroenterol Hepatol. 2018 Mar;3(3):153-161. doi: 10.1016/S2468-1253(17)30404-1. Epub 2018 Jan 6. Lancet Gastroenterol Hepatol. 2018. PMID: 29310928 Free article. Clinical Trial.
Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection.
Phetsouphanh C, Jacka B, Ballouz S, Jackson KJL, Wilson DB, Manandhar B, Klemm V, Tan HX, Wheatley A, Aggarwal A, Akerman A, Milogiannakis V, Starr M, Cunningham P, Turville SG, Kent SJ, Byrne A, Brew BJ, Darley DR, Dore GJ, Kelleher AD, Matthews GV. Phetsouphanh C, et al. Among authors: matthews gv. Nat Commun. 2024 Apr 17;15(1):3315. doi: 10.1038/s41467-024-47720-8. Nat Commun. 2024. PMID: 38632311 Free PMC article.
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions.
Marshall AD, Willing AR, Kairouz A, Cunningham EB, Wheeler A, O'Brien N, Perera V, Ward JW, Hiebert L, Degenhardt L, Hajarizadeh B, Colledge S, Hickman M, Jawad D, Lazarus JV, Matthews GV, Scheibe A, Vickerman P, Dore GJ, Grebely J; Global HCV and HIV Treatment Restrictions Group. Marshall AD, et al. Among authors: matthews gv. Lancet Gastroenterol Hepatol. 2024 Apr;9(4):366-382. doi: 10.1016/S2468-1253(23)00335-7. Epub 2024 Feb 15. Lancet Gastroenterol Hepatol. 2024. PMID: 38367631 Review.
Treatment of acute HCV infection.
Grebely J, Matthews GV, Dore GJ. Grebely J, et al. Among authors: matthews gv. Nat Rev Gastroenterol Hepatol. 2011 May;8(5):265-74. doi: 10.1038/nrgastro.2011.32. Epub 2011 Mar 22. Nat Rev Gastroenterol Hepatol. 2011. PMID: 21423258 Review.
HIV and hepatitis C coinfection.
Matthews GV, Rockstroh J. Matthews GV, et al. Curr Opin HIV AIDS. 2011 Nov;6(6):449-50. doi: 10.1097/COH.0b013e32834bbf85. Curr Opin HIV AIDS. 2011. PMID: 22001889 No abstract available.
Hepatitis C treatment as prevention: evidence, feasibility, and challenges.
Hajarizadeh B, Grebely J, Martinello M, Matthews GV, Lloyd AR, Dore GJ. Hajarizadeh B, et al. Among authors: matthews gv. Lancet Gastroenterol Hepatol. 2016 Dec;1(4):317-327. doi: 10.1016/S2468-1253(16)30075-9. Epub 2016 Nov 10. Lancet Gastroenterol Hepatol. 2016. PMID: 28404202 Review.
The APPRISE Virtual Biobank for Infectious Diseases.
Smith MZ, Turner M, Haurat J, Thevarajan I, Denholm J, Tong SY, Matthews GV, Bull RA, Martinello M, McMahon J, Imrie A, Pillai PE. Smith MZ, et al. Among authors: matthews gv. Commun Dis Intell (2018). 2023 Nov 16;47. doi: 10.33321/cdi.2023.47.66. Commun Dis Intell (2018). 2023. PMID: 37968063 Free article.
174 results